COVID-19 Vaccines in Different Countries – Janssen

While there is no information regarding when Russia, Brazil, India, and Latin America are expected to receive doses of Janssen’s COVID-19 vaccine, the company anticipates that its COVID-19 vaccine will be approved for emergency use authorization in early 2021. The company also plans to deliver around 500 million doses of its COVID-19 vaccine to lower-income countries from mid-2021.

Also, check out our research on;

• COVID-19 Vaccination Plans: Nebraska, Nevada, New Hampshire
• COVID-19 Vaccination Plans: New Jersey, New Mexico, New York
• COVID-19 Vaccination Plans: North Carolina, North Dakota, Ohio
• COVID-19 Vaccination Plans: Oklahoma, Oregon, Rhode Island
• COVID-19 Vaccination Plans: South Carolina, South Dakota, Tennessee
• COVID-19 Vaccination Plans: Texas, Utah, Vermont
• COVID-19 Vaccination Plans: Virginia, Washington, West Virginia
• COVID-19 Vaccination Plans: Wisconsin, Wyoming
• COVID-19 Vaccination Plans: Alabama, Alaska, Arizona
• COVID-19 Vaccination Plans: Arkansas, California, Colorado
• COVID-19 Vaccination Plans: Connecticut, Delaware, Florida
• COVID-19 Vaccination Plans: Georgia, Idaho, Illinois
• COVID-19 Vaccination Plans: Indiana, Iowa, Kansas
• COVID-19 Vaccination Plans: Kentucky, Louisiana, Maine
• COVID-19 Vaccination Plans: Maryland, Massachusetts, Michigan
• COVID-19 Vaccination Plans: Mississippi, Missouri, Montana
• COVID-19 Vaccine for African Americans
• U.S Vaccine Roll-Out Information
• How U.S. Federal and State Governments are Supporting Employees During the Coronavirus Pandemic
• The Use of Contact Tracing to Fight COVID-19
• Flu/Covid Testing Products
• COVID-19 Vaccine Packaging and Distribution
• COVID-19 Vaccine – Moderna; Timeline in U.S., U.K., E.U., China, Japan & Canada
• COVID-19 Vaccine – Pfizer; Timeline in U.S., U.K., E.U., China, Japan & Canada
• COVID-19 Vaccine – Novavax; Timeline in U.S., U.K., E.U., China, Japan & Canada
• COVID-19 Vaccine – Janssen; Timeline in U.S., U.K., E.U., China, Japan & Canada
• COVID-19 Vaccine – AstraZeneca; Timeline in U.S., U.K., E.U., China, Japan & Canada
• COVID-19 Vaccines in Different Countries – AstraZeneca
• COVID-19 Vaccines in Different Countries – Moderna
• COVID-19 Vaccines in Different Countries – Novavax
• COVID-19 Vaccines in Different Countries – Pfizer
• COVID-19 Long Haul Research
• Why was the COVID-19 Vaccine Developed So Quickly?
• Types of COVD-19 Vaccine
• COVID-19 and Medical Advances

Janssen’s COVID-19 Vaccine Availability

• Johnson & Johnson is scaling up its production capacity and is on track to attain its goal of delivering one billion doses of its COVID-19 vaccine each year starting from 2021.
• The company expects that the first doses of its COVID-19 vaccine will be made available for “emergency use authorization” in early 2021 after its safety and effectiveness have been proven.
• Johnson & Johnson partnered with India-based Biological E to help meet its projected vaccine production demand.
• Biological E is expected to produce over 165 million doses of Johnson & Johnson’s COVID-19 vaccine through a technology transfer agreement.
• Bill and Melinda Gates, co-chairs of the Bill & Melinda Gates Foundation, and 16 life science companies including Johnson & Johnson signed a historic Communiqué on Expanded Global Access commitment in September 2020.
• The agreement was to guarantee that people all over the world are able to access the potential COVID-19 vaccines being developed by the companies, in spite of their income level.
• The agreement urges all stakeholders, including governments and NGOs to participate in the cause and assist in ending the pandemic.
• Johnson & Johnson’s commitment includes the allocation of around 500 million doses of its COVID-19 vaccine to lower-income countries beginning from mid-2021.